Literature DB >> 5533320

Necrotizing pulmonary aspergillosis.

W P Kennedy, D N Malone, W Blyth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5533320      PMCID: PMC472211          DOI: 10.1136/thx.25.6.691

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  23 in total

1.  PULMONARY ASPERGILLOSIS: DIAGNOSTIC AND IMMUNOLOGICAL SIGNIFICANCE OF ANTIGENS AND C-SUBSTANCE IN ASPERGILLUS FUMIGATUS.

Authors:  J L LONGBOTTOM; J PEPYS
Journal:  J Pathol Bacteriol       Date:  1964-07

2.  THE TREATMENT OF BRONCHOPULMONARY MYCOSES WITH A NEW ANTIBIOTIC--PIMARICIN.

Authors:  G EDWARDS; C J LATOUCHE
Journal:  Lancet       Date:  1964-06-20       Impact factor: 79.321

3.  BRONCHOPULMONARY ASPERGILLOSIS. A CORRELATION OF THE CLINICAL AND LABORATORY FINDINGS IN 272 PATIENTS INVESTIGATED FOR BRONCHOPULMONARY ASPERGILLOSIS.

Authors:  M J CAMPBELL; Y M CLAYTON
Journal:  Am Rev Respir Dis       Date:  1964-02

4.  Tracheobronchopulmonary mycoses caused by opportunistic fungi, with particular reference to aspergillosis.

Authors:  M OKUDAIRA; J SCHWARTZ
Journal:  Lab Invest       Date:  1962-11       Impact factor: 5.662

5.  Growth of Aspergillus in the human lung. Aspergilloma and aspergillosis.

Authors:  N G ORIE; G A DE VRIES; A KIKSTRA
Journal:  Am Rev Respir Dis       Date:  1960-11

6.  A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic.

Authors:  R G GROCOTT
Journal:  Am J Clin Pathol       Date:  1955-08       Impact factor: 2.493

7.  Primary disseminated pulmonary aspergillosis with metastatic skin nodules. Successful treatment with inhalation nystatin therapy.

Authors:  J S Vedder; W F Schorr
Journal:  JAMA       Date:  1969-08-25       Impact factor: 56.272

8.  Interactions between some aural aspergillus species and bacteria.

Authors:  A Mangan
Journal:  J Gen Microbiol       Date:  1969-10

9.  An analysis of factors predisposing to gram-negative bacillary necrotizing pneumonia.

Authors:  A K Pierce; E B Edmonson; G McGee; J Ketchersid; R G Loudon; J P Sanford
Journal:  Am Rev Respir Dis       Date:  1966-09

10.  Significance and interpretation of laboratory tests in pulmonary aspergillosis.

Authors:  M P English; A H Henderson
Journal:  J Clin Pathol       Date:  1967-11       Impact factor: 3.411

View more
  7 in total

1.  What happens to patients with pulmonary aspergilloma? Analysis of 23 cases.

Authors:  P Rafferty; B A Biggs; G K Crompton; I W Grant
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

2.  Hypersensitivity pneumonitis due to Aspergillus fumigatus in compost.

Authors:  W Vincken; P Roels
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

3.  Necrotising pulmonary aspergillosis complicating the management of patients with obstructive airways disease.

Authors:  P J George; P B Boffa; C P Naylor; T W Higenbottam
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

4.  Pulmonary aspergillosis caused by Aspergillus flavus.

Authors:  E S Mahgoub; A M el-Hassan
Journal:  Thorax       Date:  1972-01       Impact factor: 9.139

5.  Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis.

Authors:  M A Nalesnik; R L Myerowitz; R Jenkins; J Lenkey; D Herbert
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

6.  Saprophytic invasion of infarcted pulmonary tissue by Aspergillus species.

Authors:  D R Buchanan; D Lamb
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

7.  A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL).

Authors:  Findra Setianingrum; Anna Rozaliyani; Robiatul Adawiyah; Ridhawati Syam; Mulyati Tugiran; Cut Yulia Indah Sari; Finny Nandipinto; Johannes Ramnath; Arief Riadi Arifin; Diah Handayani; Erlina Burhan; Martin Rumende; Retno Wahyuningsih; Riina Rautemaa-Richardson; David W Denning
Journal:  Thorax       Date:  2021-11-30       Impact factor: 9.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.